Zhongxing BioTech released its first-quarter performance, with a net profit attributable to the parent company of 48.2002 million yuan, a year-on-year increase of 38.72%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Zhongxing BioTech released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 473 million yuan, a year-on-year decrease of 2.89%. The net profit attributable to shareholders of the listed company was 48.2002 million yuan, a year-on-year increase of 38.72%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 45.6542 million yuan, a year-on-year increase of 57.01%
According to the Zhitong Finance APP, Zhongxing BioTech (002772.SZ) released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 473 million yuan, a year-on-year decrease of 2.89%. The net profit attributable to shareholders of the listed company was 48.2002 million yuan, a year-on-year increase of 38.72%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 45.6542 million yuan, a year-on-year increase of 57.01%